Currently, Sung H. Lee holds the position of Chief Financial Officer at MorphoSys AG.

In his past career he occupied the position of Chief Financial Officer & Executive Vice President of Sangamo Therapeutics, Inc. and Vice President-Investor Relations of Gilead Sciences, Inc.

He received an undergraduate degree from the University of California, Irvine and a graduate degree from the University of Southern California.